Project acronym AUTOCOMPLEMENT
Project The role of complement in the induction of autoimmunity against post-translationally modified proteins
Researcher (PI) Leendert TROUW
Host Institution (HI) ACADEMISCH ZIEKENHUIS LEIDEN
Call Details Consolidator Grant (CoG), LS7, ERC-2016-COG
Summary In many prevalent autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) autoantibodies are used as diagnostic and prognostic tools. Several of these autoantibodies target proteins that have been post-translationally modified (PTM). Examples of such modifications are citrullination and carbamylation. The success of B cell-targeted therapies in many auto-antibody positive diseases suggests that B cell mediated auto-immunity is playing a direct pathogenic role. Despite the wealth of information on the clinical associations of these anti-PTM protein antibodies as biomarkers we have currently no insight into why these antibodies are formed.
Immunization studies reveal that PTM proteins can induce antibody responses even in the absence of exogenous adjuvant. The reason why these PTM proteins have ‘autoadjuvant’ properties that lead to a breach of tolerance is currently unknown. In this proposal, I hypothesise that the breach of tolerance towards PTM proteins is mediated by complement factors that bind directly to these PTM. Our preliminary data indeed reveal that several complement factors bind specifically to PTM proteins. Complement could be involved in the autoadjuvant property of PTM proteins as next to killing pathogens complement can also boost adaptive immune responses. I plan to unravel the importance of the complement–PTM protein interaction by answering these questions:
1) What is the physiological function of complement binding to PTM proteins?
2) Is the breach of tolerance towards PTM proteins influenced by complement?
3) Can the adjuvant function of PTM be used to increase vaccine efficacy and/or decrease autoreactivity?
With AUTOCOMPLEMENT I will elucidate how PTM-reactive B cells receive ‘autoadjuvant’ signals. This insight will impact on patient care as we can now design strategies to either block unwanted ‘autoadjuvant’ signals to inhibit autoimmunity or to utilize ‘autoadjuvant’ signals to potentiate vaccination.
Summary
In many prevalent autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) autoantibodies are used as diagnostic and prognostic tools. Several of these autoantibodies target proteins that have been post-translationally modified (PTM). Examples of such modifications are citrullination and carbamylation. The success of B cell-targeted therapies in many auto-antibody positive diseases suggests that B cell mediated auto-immunity is playing a direct pathogenic role. Despite the wealth of information on the clinical associations of these anti-PTM protein antibodies as biomarkers we have currently no insight into why these antibodies are formed.
Immunization studies reveal that PTM proteins can induce antibody responses even in the absence of exogenous adjuvant. The reason why these PTM proteins have ‘autoadjuvant’ properties that lead to a breach of tolerance is currently unknown. In this proposal, I hypothesise that the breach of tolerance towards PTM proteins is mediated by complement factors that bind directly to these PTM. Our preliminary data indeed reveal that several complement factors bind specifically to PTM proteins. Complement could be involved in the autoadjuvant property of PTM proteins as next to killing pathogens complement can also boost adaptive immune responses. I plan to unravel the importance of the complement–PTM protein interaction by answering these questions:
1) What is the physiological function of complement binding to PTM proteins?
2) Is the breach of tolerance towards PTM proteins influenced by complement?
3) Can the adjuvant function of PTM be used to increase vaccine efficacy and/or decrease autoreactivity?
With AUTOCOMPLEMENT I will elucidate how PTM-reactive B cells receive ‘autoadjuvant’ signals. This insight will impact on patient care as we can now design strategies to either block unwanted ‘autoadjuvant’ signals to inhibit autoimmunity or to utilize ‘autoadjuvant’ signals to potentiate vaccination.
Max ERC Funding
1 999 803 €
Duration
Start date: 2017-09-01, End date: 2022-08-31
Project acronym Bio-ICD
Project Biological auto-detection and termination of heart rhythm disturbances
Researcher (PI) Daniël Antonie PIJNAPPELS
Host Institution (HI) ACADEMISCH ZIEKENHUIS LEIDEN
Call Details Starting Grant (StG), LS7, ERC-2016-STG
Summary Imagine a heart that could no longer suffer from life-threatening rhythm disturbances, and not because of pills or traumatizing electroshocks from an Implantable Cardioverter Defibrillator (ICD) device. Instead, this heart has become able to rapidly detect & terminate these malignant arrhythmias fully on its own, after gene transfer. In order to explore this novel concept of biological auto-detection & termination of arrhythmias, I will investigate how forced expression of particular engineered proteins could i) allow cardiac tissue to become a detector of arrhythmias through rapid sensing of acute physiological changes upon their initiation. And how after detection, ii) this cardiac tissue (now as effector), could terminate the arrhythmia by generating a painless electroshock through these proteins.
To this purpose, I will first explore the requirements for such detection & termination by studying arrhythmia initiation and termination in rat models of atrial & ventricular arrhythmias using optical probes and light-gated ion channels. These insights will guide computer-based screening of proteins to identify those properties allowing effective arrhythmia detection & termination. These data will be used for rational engineering of the proteins with the desired properties, followed by their forced expression in cardiac cells and slices to assess anti-arrhythmic potential & safety. Promising proteins will be expressed in whole hearts to study their anti-arrhythmic effects and mechanisms, after which the most effective ones will be studied in awake rats.
This unexplored concept of self-resetting an acutely disturbed physiological state by establishing a biological detector-effector system may yield unique insight into arrhythmia management. Hence, this could provide distinctively innovative therapeutic rationales in which a diseased organ begets its own remedy, e.g. a Biologically-Integrated Cardiac Defibrillator (Bio-ICD).
Summary
Imagine a heart that could no longer suffer from life-threatening rhythm disturbances, and not because of pills or traumatizing electroshocks from an Implantable Cardioverter Defibrillator (ICD) device. Instead, this heart has become able to rapidly detect & terminate these malignant arrhythmias fully on its own, after gene transfer. In order to explore this novel concept of biological auto-detection & termination of arrhythmias, I will investigate how forced expression of particular engineered proteins could i) allow cardiac tissue to become a detector of arrhythmias through rapid sensing of acute physiological changes upon their initiation. And how after detection, ii) this cardiac tissue (now as effector), could terminate the arrhythmia by generating a painless electroshock through these proteins.
To this purpose, I will first explore the requirements for such detection & termination by studying arrhythmia initiation and termination in rat models of atrial & ventricular arrhythmias using optical probes and light-gated ion channels. These insights will guide computer-based screening of proteins to identify those properties allowing effective arrhythmia detection & termination. These data will be used for rational engineering of the proteins with the desired properties, followed by their forced expression in cardiac cells and slices to assess anti-arrhythmic potential & safety. Promising proteins will be expressed in whole hearts to study their anti-arrhythmic effects and mechanisms, after which the most effective ones will be studied in awake rats.
This unexplored concept of self-resetting an acutely disturbed physiological state by establishing a biological detector-effector system may yield unique insight into arrhythmia management. Hence, this could provide distinctively innovative therapeutic rationales in which a diseased organ begets its own remedy, e.g. a Biologically-Integrated Cardiac Defibrillator (Bio-ICD).
Max ERC Funding
1 485 028 €
Duration
Start date: 2017-03-01, End date: 2022-02-28
Project acronym DYNAMINT
Project Dynamics of Probed, Pulsed, Quenched and Driven Integrable Quantum Systems
Researcher (PI) Jean-Sébastien CAUX
Host Institution (HI) UNIVERSITEIT VAN AMSTERDAM
Call Details Advanced Grant (AdG), PE2, ERC-2016-ADG
Summary This proposal intends to develop and apply a new-generation theoretical toolbox for understanding the rich dynamics of strongly-interacting many-body quantum sytems subjected to destabilizing manipulations bringing them very far from equilibrium.
In atomic systems, condensed matter and nanophysics settings, quantum matter is nowadays routinely pushed beyond the traditional low-energy/linear response/thermal equilibrium paradigms. Some experiments even clearly highlight the need to revise basic fundamental quantum statistical mechanics notions such as ergodicity, relaxation and thermalization in order to explain their behaviour. Theory must thus urgently revise its textbooks and develop new interpretations and capabilities for offering concrete, quantitative phenomenology.
This proposal is focused on a set of systems at the very center of this strongly-correlated, experimentally realizable far-from-equilibrium spectacle: integrable models of quantum spin chains, interacting gases confined to one spatial dimension, and quantum dots. Building up on recent theoretical breakthroughs in dynamical correlations and post-quench steady states, this proposal aims to shed a new light on the fundamental principles at the heart of many-body quantum dynamics. It will implement a broad and ambitious research agenda consisting of synergetic projects from mathematically formal thought experiments all the way to phenomenologically applied practical calculations. The types of protocols to be studied include probes creating high-energy excitations, pulses inducing changes beyond linear response, quenches causing sudden global reorganizations, all the way to drivings completely metamorphozing the physical states.
The result will be to provide reliable, experimentally relevant and urgently-needed theoretical `anchoring points' in our general understanding of the physics underlying far-from-equilibrium strongly-interacting quantum matter.
Summary
This proposal intends to develop and apply a new-generation theoretical toolbox for understanding the rich dynamics of strongly-interacting many-body quantum sytems subjected to destabilizing manipulations bringing them very far from equilibrium.
In atomic systems, condensed matter and nanophysics settings, quantum matter is nowadays routinely pushed beyond the traditional low-energy/linear response/thermal equilibrium paradigms. Some experiments even clearly highlight the need to revise basic fundamental quantum statistical mechanics notions such as ergodicity, relaxation and thermalization in order to explain their behaviour. Theory must thus urgently revise its textbooks and develop new interpretations and capabilities for offering concrete, quantitative phenomenology.
This proposal is focused on a set of systems at the very center of this strongly-correlated, experimentally realizable far-from-equilibrium spectacle: integrable models of quantum spin chains, interacting gases confined to one spatial dimension, and quantum dots. Building up on recent theoretical breakthroughs in dynamical correlations and post-quench steady states, this proposal aims to shed a new light on the fundamental principles at the heart of many-body quantum dynamics. It will implement a broad and ambitious research agenda consisting of synergetic projects from mathematically formal thought experiments all the way to phenomenologically applied practical calculations. The types of protocols to be studied include probes creating high-energy excitations, pulses inducing changes beyond linear response, quenches causing sudden global reorganizations, all the way to drivings completely metamorphozing the physical states.
The result will be to provide reliable, experimentally relevant and urgently-needed theoretical `anchoring points' in our general understanding of the physics underlying far-from-equilibrium strongly-interacting quantum matter.
Max ERC Funding
2 444 446 €
Duration
Start date: 2017-09-01, End date: 2022-08-31
Project acronym EVICARE
Project Extracellular Vesicle-Inspired CArdiac Repair
Researcher (PI) Joseph Petrus Gerardus SLUIJTER
Host Institution (HI) UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Call Details Consolidator Grant (CoG), LS7, ERC-2016-COG
Summary More than 3.5 million people are newly diagnosed with heart failure every year in Europe with a long-term prognosis of 50% mortality within 4 years. There is a major need for more innovative, regenerative therapies that have the potential to change the course of disease. My hypothesis is that we can recondition heart failure by stimulating cardiac repair with extracellular vesicles that are derived from progenitor cells. In my laboratory, extracellular released vesicles containing a cocktail of stimulating factors, are amongst the most potent vectors for cardiac repair.
To achieve a sustainable and long-term therapeutic effect of these vesicles and enhance cardiac function by stimulating myocardial repair, we will 1) improve local cardiac delivery of progenitor cell-derived extracellular vesicles, 2) understand the mechanism of action of extracellular vesicles, and 3) stimulate extracellular vesicles release and/or production by progenitor cells.
These questions form the rationale for the current proposal in which we will co-inject extracellular vesicles and slow-release biomaterials into the damaged myocardium. By subsequent genetic tracing, we will determine fate mapping of injected vesicles in vivo, and perform further mechanistic understanding in in vitro culture models of targeted and identified myocardial cell types. Moreover, we will upscale the vesicles production by progenitor cells further via bioreactor culturing and medium-throughput screening on factors that stimulate vesicles release.
The use of stem cell-derived extracellular vesicles to stimulate cardiac repair will potentially allow for an off-the shelf approach, including mechanistic understanding and future clinical use. Additionally, since these vesicles act as a natural carrier system outperforming current artificial drug delivery, we might understand and mimic their characteristics to enhance local (RNA-based) drug delivery systems for cardiovascular application.
Summary
More than 3.5 million people are newly diagnosed with heart failure every year in Europe with a long-term prognosis of 50% mortality within 4 years. There is a major need for more innovative, regenerative therapies that have the potential to change the course of disease. My hypothesis is that we can recondition heart failure by stimulating cardiac repair with extracellular vesicles that are derived from progenitor cells. In my laboratory, extracellular released vesicles containing a cocktail of stimulating factors, are amongst the most potent vectors for cardiac repair.
To achieve a sustainable and long-term therapeutic effect of these vesicles and enhance cardiac function by stimulating myocardial repair, we will 1) improve local cardiac delivery of progenitor cell-derived extracellular vesicles, 2) understand the mechanism of action of extracellular vesicles, and 3) stimulate extracellular vesicles release and/or production by progenitor cells.
These questions form the rationale for the current proposal in which we will co-inject extracellular vesicles and slow-release biomaterials into the damaged myocardium. By subsequent genetic tracing, we will determine fate mapping of injected vesicles in vivo, and perform further mechanistic understanding in in vitro culture models of targeted and identified myocardial cell types. Moreover, we will upscale the vesicles production by progenitor cells further via bioreactor culturing and medium-throughput screening on factors that stimulate vesicles release.
The use of stem cell-derived extracellular vesicles to stimulate cardiac repair will potentially allow for an off-the shelf approach, including mechanistic understanding and future clinical use. Additionally, since these vesicles act as a natural carrier system outperforming current artificial drug delivery, we might understand and mimic their characteristics to enhance local (RNA-based) drug delivery systems for cardiovascular application.
Max ERC Funding
1 997 298 €
Duration
Start date: 2017-09-01, End date: 2022-08-31
Project acronym GenGeoHol
Project Non AdS holography and generalized geometric structures
Researcher (PI) Diego HOFMAN
Host Institution (HI) UNIVERSITEIT VAN AMSTERDAM
Call Details Starting Grant (StG), PE2, ERC-2016-STG
Summary Holography is by now a fundamental tool in the understanding of both strongly coupled conformal field theories (CFTs) and quantum theories of gravity. While holography in Anti de Sitter (AdS) space-times is rather well understood, we currently lack a basic picture of what it means in non-AdS space-times. Considering non-AdS space-times is an essential and urgent next step in the study of quantum gravity as we seem to live in a universe with a positive cosmological constant that is approaching de Sitter (dS) in the far future. Also, the near-horizon geometries of black holes are typically described by more exotic geometries that need to be understood on their own right.
I propose to address this and study the physics of holographic systems on non-AdS space-times and their connection to generalized geometric structures that naturally arise in these setups. In order do this I will use both conventional field theory techniques and new holographic tools, some of which I have developed recently.
The relevance of GenGeoHol is illustrated by universal properties of black holes, e.g. their area-law entropy. These are independent of AdS, pointing towards the existence of a more general holographic principle that generalizes the usual symmetries and geometric notions. A great deal of evidence has accumulated recently indicating that this is indeed the case. The physics of extremal black holes and non relativistic systems are clear examples.
GenGeoHol will impact a wide range of fields. As one moves away from AdS Einstein gravity, the dual quantum-field theories present different symmetries from that of usual relativistic systems. These systems couple naturally to generalized background geometries which are of intrinsic interest and key to a range of concepts extending from Newton-Cartan geometry in non-relativistic systems to higher-spin geometries for so-called W_N CFTs.
Given my experience and track record, I am uniquely positioned to attack this problem successfully.
Summary
Holography is by now a fundamental tool in the understanding of both strongly coupled conformal field theories (CFTs) and quantum theories of gravity. While holography in Anti de Sitter (AdS) space-times is rather well understood, we currently lack a basic picture of what it means in non-AdS space-times. Considering non-AdS space-times is an essential and urgent next step in the study of quantum gravity as we seem to live in a universe with a positive cosmological constant that is approaching de Sitter (dS) in the far future. Also, the near-horizon geometries of black holes are typically described by more exotic geometries that need to be understood on their own right.
I propose to address this and study the physics of holographic systems on non-AdS space-times and their connection to generalized geometric structures that naturally arise in these setups. In order do this I will use both conventional field theory techniques and new holographic tools, some of which I have developed recently.
The relevance of GenGeoHol is illustrated by universal properties of black holes, e.g. their area-law entropy. These are independent of AdS, pointing towards the existence of a more general holographic principle that generalizes the usual symmetries and geometric notions. A great deal of evidence has accumulated recently indicating that this is indeed the case. The physics of extremal black holes and non relativistic systems are clear examples.
GenGeoHol will impact a wide range of fields. As one moves away from AdS Einstein gravity, the dual quantum-field theories present different symmetries from that of usual relativistic systems. These systems couple naturally to generalized background geometries which are of intrinsic interest and key to a range of concepts extending from Newton-Cartan geometry in non-relativistic systems to higher-spin geometries for so-called W_N CFTs.
Given my experience and track record, I am uniquely positioned to attack this problem successfully.
Max ERC Funding
1 300 775 €
Duration
Start date: 2017-09-01, End date: 2022-08-31
Project acronym LUPUSCARE
Project PRECISION CARE IN SYSTEMIC AUTOIMMUNITY: AN INTEGRATED MULTI-TISSUE/LEVEL APPROACH FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Researcher (PI) DIMITRIOS BOUMPAS
Host Institution (HI) IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON
Call Details Advanced Grant (AdG), LS7, ERC-2016-ADG
Summary Systemic lupus erythematosus (SLE) is a heterogeneous disease whereby an interplay of environmental, genetic and epigenetic factors lead to perturbation of complex biological networks culminating into diverse clinical phenotypes of varying severity. High throughput methods have allowed an “initial glimpse” into pathogenesis and have laid the foundations for a molecular-based taxonomy for personalized therapy. Based on our experience with the molecular characterization of SLE, a recently completed RNA sequencing analysis of 150 patients, and our track- record of “paradigm shift” trials in SLE, we will integrate data from multi-tissue analyses with novel technologies to improve its diagnosis, monitoring and therapy, and ask fundamental pathogenetic questions in systemic autoimmunity. More specifically, we will design gene expression panels and “expression profile”/”clinical trait” correlation matrices for diagnostics, personalized immunotherapy and improved clinical trial design. In a systematic multi-tissue approach, we will examine the role of somatic mutations in enhancing immune hyperactivity and the risk for lymphoma. The staggering (7-9:1) female predominance will be elucidated through elaborate genomic, epigenomic and microbiota analyses of family trios. Finally, we will be pursuing the innovative hypothesis that the fundamental abnormalities of SLE lie within the bone marrow hematopoietic stem cells (HSCs) - from which all cells that participate in the pathogenesis of SLE originate - and establish it as a unifying pathogenetic mechanism. By a combination of novel experimental analyses with single cell genomics, multi–omics, humanized animal models, genome editing and an “organ on-a-chip” device, we will validate HSCs as a therapeutic target. The utility of SLE research extends beyond its boundaries, by providing unique insights as to how the immune system recognizes self-constituents and maintains its homeostasis, and how gender impacts on disease biology.
Summary
Systemic lupus erythematosus (SLE) is a heterogeneous disease whereby an interplay of environmental, genetic and epigenetic factors lead to perturbation of complex biological networks culminating into diverse clinical phenotypes of varying severity. High throughput methods have allowed an “initial glimpse” into pathogenesis and have laid the foundations for a molecular-based taxonomy for personalized therapy. Based on our experience with the molecular characterization of SLE, a recently completed RNA sequencing analysis of 150 patients, and our track- record of “paradigm shift” trials in SLE, we will integrate data from multi-tissue analyses with novel technologies to improve its diagnosis, monitoring and therapy, and ask fundamental pathogenetic questions in systemic autoimmunity. More specifically, we will design gene expression panels and “expression profile”/”clinical trait” correlation matrices for diagnostics, personalized immunotherapy and improved clinical trial design. In a systematic multi-tissue approach, we will examine the role of somatic mutations in enhancing immune hyperactivity and the risk for lymphoma. The staggering (7-9:1) female predominance will be elucidated through elaborate genomic, epigenomic and microbiota analyses of family trios. Finally, we will be pursuing the innovative hypothesis that the fundamental abnormalities of SLE lie within the bone marrow hematopoietic stem cells (HSCs) - from which all cells that participate in the pathogenesis of SLE originate - and establish it as a unifying pathogenetic mechanism. By a combination of novel experimental analyses with single cell genomics, multi–omics, humanized animal models, genome editing and an “organ on-a-chip” device, we will validate HSCs as a therapeutic target. The utility of SLE research extends beyond its boundaries, by providing unique insights as to how the immune system recognizes self-constituents and maintains its homeostasis, and how gender impacts on disease biology.
Max ERC Funding
2 355 000 €
Duration
Start date: 2017-09-01, End date: 2022-08-31
Project acronym MECHANOSENSATION
Project What is the molecular mechanism of mechanosensation? Mechanosensitive channel of large conductance, MscL, as a model
Researcher (PI) Armagan Kocer
Host Institution (HI) RIJKSUNIVERSITEIT GRONINGEN
Call Details Starting Grant (StG), LS7, ERC-2007-StG
Summary “Equipped with his five senses, man explores the universe around him and calls the adventure science” E.P. Hubble It is amazing how much we have learned about the working of our universe by using our five senses and how little we still know about the working of these senses themselves! Even though the molecular mechanism of sight, taste, and smell is known, we still don’t know how the mechanical sensations of touch and hearing function at the molecular level. Mechanosensitive (MS) ion channels, present in membranes, are the molecules that sense membrane tension in all species ranging from bacteria to man. They stay functional even in artificial membranes, indicating that mechanosensation occurs at the protein-lipid interface. In an effort to understand the mechanism of force sensation, the major limitation has been the inability to ‘observe’ the molecular changes occurring in MS channels from the onset of the force. The aim of this proposal is to understand how channel proteins sense mechanical force at the molecular level. A bacterial channel, MscL, will be used as a model for its natural function to couple tension in the membrane to protein conformational changes. Here, on the basis of my recent findings, I propose to build on synthetic biology approaches to develop unique tools to specifically address the MS channel, allowing controlling its activity extrinsically and reversibly. In combination with the spectroscopic techniques, I want to elucidate the mechanism of mechanosensation in MscL by measuring structural changes in the protein and its interaction with the surrounding lipids, starting from the onset of the force. The research will clarify not only the long-standing question of how MscL senses tension, but it will also shed light on the common property of mechanosensitivity among nature’s sensors in higher organisms; transient receptor-potential (TRP) channels, which are involved in hearing, touching and other sensory actions.
Summary
“Equipped with his five senses, man explores the universe around him and calls the adventure science” E.P. Hubble It is amazing how much we have learned about the working of our universe by using our five senses and how little we still know about the working of these senses themselves! Even though the molecular mechanism of sight, taste, and smell is known, we still don’t know how the mechanical sensations of touch and hearing function at the molecular level. Mechanosensitive (MS) ion channels, present in membranes, are the molecules that sense membrane tension in all species ranging from bacteria to man. They stay functional even in artificial membranes, indicating that mechanosensation occurs at the protein-lipid interface. In an effort to understand the mechanism of force sensation, the major limitation has been the inability to ‘observe’ the molecular changes occurring in MS channels from the onset of the force. The aim of this proposal is to understand how channel proteins sense mechanical force at the molecular level. A bacterial channel, MscL, will be used as a model for its natural function to couple tension in the membrane to protein conformational changes. Here, on the basis of my recent findings, I propose to build on synthetic biology approaches to develop unique tools to specifically address the MS channel, allowing controlling its activity extrinsically and reversibly. In combination with the spectroscopic techniques, I want to elucidate the mechanism of mechanosensation in MscL by measuring structural changes in the protein and its interaction with the surrounding lipids, starting from the onset of the force. The research will clarify not only the long-standing question of how MscL senses tension, but it will also shed light on the common property of mechanosensitivity among nature’s sensors in higher organisms; transient receptor-potential (TRP) channels, which are involved in hearing, touching and other sensory actions.
Max ERC Funding
1 449 236 €
Duration
Start date: 2008-09-01, End date: 2014-02-28
Project acronym MOLFOUNTAIN
Project Precision measurements on cold molecules in a fountain
Researcher (PI) Hendrick Lucas Bethlem
Host Institution (HI) STICHTING VU
Call Details Starting Grant (StG), PE2, ERC-2007-StG
Summary In a recent series of experiments, it has been shown that polar molecules can be decelerated, bunched, cooled, and trapped using time-varying electric fields. These experiments demonstrate an unprecedented level of control over molecules, which enables a variety of applications of great scientific interest. Here, I propose to use these techniques to create a molecular fountain. In this fountain, the first of its kind, polar molecules are decelerated, cooled, and subsequently launched upwards some 10-50 cm before falling back under gravity, thereby passing a microwave cavity or laser beam twice – as they fly up and as they fall back down. The effective interrogation time in such a Ramsey type measurement scheme includes the entire flight time between the two traversals through the driving field, which can be up to a second. This long interrogation time will allow for extreme precision measurements on molecular structure to a level at which fundamental physics theories can be tested. I will use the inversion frequency in ammonia around 23 GHz as a test case. This transition is very well studied and was used in the first ‘atomic’ clock and the first demonstration of a MASER. The fountain should make it possible to measure the inversion frequency with a relative accuracy of 10^{-12}–10^{-14}; that is more than a thousand fold improvement as compared to the best previous measurement. Besides serving as a proof-of-principle, this measurement may be used as a test of the time-variation of fundamental constants – an issue that has profound implications on how we understand the universe. The inversion frequency in ammonia is determined by the tunneling rate of the protons through the barrier between the two equivalent configurations of the molecule, and is exponentially dependent on the proton mass. By monitoring the inversion frequency over a period of a few years, a possible variation of the proton-electron mass ratio can be constrained or measured.
Summary
In a recent series of experiments, it has been shown that polar molecules can be decelerated, bunched, cooled, and trapped using time-varying electric fields. These experiments demonstrate an unprecedented level of control over molecules, which enables a variety of applications of great scientific interest. Here, I propose to use these techniques to create a molecular fountain. In this fountain, the first of its kind, polar molecules are decelerated, cooled, and subsequently launched upwards some 10-50 cm before falling back under gravity, thereby passing a microwave cavity or laser beam twice – as they fly up and as they fall back down. The effective interrogation time in such a Ramsey type measurement scheme includes the entire flight time between the two traversals through the driving field, which can be up to a second. This long interrogation time will allow for extreme precision measurements on molecular structure to a level at which fundamental physics theories can be tested. I will use the inversion frequency in ammonia around 23 GHz as a test case. This transition is very well studied and was used in the first ‘atomic’ clock and the first demonstration of a MASER. The fountain should make it possible to measure the inversion frequency with a relative accuracy of 10^{-12}–10^{-14}; that is more than a thousand fold improvement as compared to the best previous measurement. Besides serving as a proof-of-principle, this measurement may be used as a test of the time-variation of fundamental constants – an issue that has profound implications on how we understand the universe. The inversion frequency in ammonia is determined by the tunneling rate of the protons through the barrier between the two equivalent configurations of the molecule, and is exponentially dependent on the proton mass. By monitoring the inversion frequency over a period of a few years, a possible variation of the proton-electron mass ratio can be constrained or measured.
Max ERC Funding
1 100 000 €
Duration
Start date: 2008-08-01, End date: 2013-07-31
Project acronym OPTICALBULLET
Project Studies of neurosecretion by remote control of exocytosis and endocytosis with ligt
Researcher (PI) Pau Gorostiza
Host Institution (HI) FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
Call Details Starting Grant (StG), LS7, ERC-2007-StG
Summary Optical switches are photoisomerizable compounds that allow to remotely controlling the activity of proteins, cells and entire organisms with light. These tools are revolutionizing research in biology with their high selectivity and spatiotemporal resolution. Here we propose to develop and apply optical switches to investigate the fundamental processes of secretion, exocytosis and endocytosis, in a way that is non-invasive, acute, and orthogonal to pharmacological and electrophysiological techniques. The optical control of exocytosis will be carried out by means of photoswitchable, Ca2+-permeable channels (LiGluR and Channelrhodopsin-2) which allow triggering vesicle fusion at single synaptic terminals. This procedure will allow studying vesicle release kinetics and the differences between synapses of the same neuron. The photocontrol of endocytosis will be carried out with: (1) inhibitory peptides of the clathrin pathway modified with an azobenzene crosslinker in order to photomodulate their structure and affinity, and (2) photoswitchable synthetic compounds based on chemical inhibitors of dynamin. Photomodulation of endocytosis in chromaffin cells and neurons will allow interfering with the internalisation of membrane receptors with an unprecedented spatial and temporal control. The use of photoswitchable inhibitors of endocytosis would allow for the first time to manipulate reversibly and with subcellular resolution, the vesicular trafficking of the endocytic pathway. In addition, these photoswitches could reveal how endocytosis regulates spatially receptor activation, controlling cell patterning and cell fate.
Summary
Optical switches are photoisomerizable compounds that allow to remotely controlling the activity of proteins, cells and entire organisms with light. These tools are revolutionizing research in biology with their high selectivity and spatiotemporal resolution. Here we propose to develop and apply optical switches to investigate the fundamental processes of secretion, exocytosis and endocytosis, in a way that is non-invasive, acute, and orthogonal to pharmacological and electrophysiological techniques. The optical control of exocytosis will be carried out by means of photoswitchable, Ca2+-permeable channels (LiGluR and Channelrhodopsin-2) which allow triggering vesicle fusion at single synaptic terminals. This procedure will allow studying vesicle release kinetics and the differences between synapses of the same neuron. The photocontrol of endocytosis will be carried out with: (1) inhibitory peptides of the clathrin pathway modified with an azobenzene crosslinker in order to photomodulate their structure and affinity, and (2) photoswitchable synthetic compounds based on chemical inhibitors of dynamin. Photomodulation of endocytosis in chromaffin cells and neurons will allow interfering with the internalisation of membrane receptors with an unprecedented spatial and temporal control. The use of photoswitchable inhibitors of endocytosis would allow for the first time to manipulate reversibly and with subcellular resolution, the vesicular trafficking of the endocytic pathway. In addition, these photoswitches could reveal how endocytosis regulates spatially receptor activation, controlling cell patterning and cell fate.
Max ERC Funding
1 338 000 €
Duration
Start date: 2008-09-01, End date: 2013-08-31
Project acronym OVO-GROWTH
Project Oogenesis spotlighted: making mature human oocytes
Researcher (PI) Susana Marina CHUVA DE SOUSA LOPES
Host Institution (HI) ACADEMISCH ZIEKENHUIS LEIDEN
Call Details Consolidator Grant (CoG), LS7, ERC-2016-COG
Summary Women who survive childhood cancer often fail to conceive because their eggs are damaged by (gonadotoxic) chemotherapy. A major breakthrough has been the possibility to cryopreserve cortical strips of their ovarian tissue for autologous transplantation later in life. This has led to over 40 successful pregnancies worldwide, the latest in the Netherlands. However, the risk of reintroducing cancer cells with the ovarian graft in patients with previous hematopoietic malignancies is too great and alternatives are needed.
Here, I propose to build on my expertise in gametogenesis in mice and humans and perform a detailed study of the cellular networks and molecular pathways that control development and maturation of the oocyte within the human ovary. We have access and ethical approval for research on human foetal tissue and postnatal ovarian biopsies over a wide age range. I will use this rare material to systematically benchmark the transcriptional profile of cells in the human ovary (oocytes as well as somatic cells) during development and adulthood using Drop-seq, a novel cost-efficient single-cell technology that allows the profiling of thousands of cells in a matter of hours. Thereafter, we will apply mathematical algorithms to reveal cellular identities, developmental trajectories and signalling networks that control oogenesis. With this knowledge, I plan to engineer a human follicular niche creating a “mini-ovary” in vitro that could support the formation and maturation of the oocyte (using patient-specific cells) and to explore mechanisms of follicle maturation through a xenotransplantation mouse model. The cellular outcomes of these assays will be sequenced using Drop-seq and directly compared to their in vivo counterparts.
Our approach will lead to more effective personalized-therapy for fertility preservation and contribute to the development of an in vitro mini-ovary organoid model to use in human reproductive toxicology and disease modelling.
Summary
Women who survive childhood cancer often fail to conceive because their eggs are damaged by (gonadotoxic) chemotherapy. A major breakthrough has been the possibility to cryopreserve cortical strips of their ovarian tissue for autologous transplantation later in life. This has led to over 40 successful pregnancies worldwide, the latest in the Netherlands. However, the risk of reintroducing cancer cells with the ovarian graft in patients with previous hematopoietic malignancies is too great and alternatives are needed.
Here, I propose to build on my expertise in gametogenesis in mice and humans and perform a detailed study of the cellular networks and molecular pathways that control development and maturation of the oocyte within the human ovary. We have access and ethical approval for research on human foetal tissue and postnatal ovarian biopsies over a wide age range. I will use this rare material to systematically benchmark the transcriptional profile of cells in the human ovary (oocytes as well as somatic cells) during development and adulthood using Drop-seq, a novel cost-efficient single-cell technology that allows the profiling of thousands of cells in a matter of hours. Thereafter, we will apply mathematical algorithms to reveal cellular identities, developmental trajectories and signalling networks that control oogenesis. With this knowledge, I plan to engineer a human follicular niche creating a “mini-ovary” in vitro that could support the formation and maturation of the oocyte (using patient-specific cells) and to explore mechanisms of follicle maturation through a xenotransplantation mouse model. The cellular outcomes of these assays will be sequenced using Drop-seq and directly compared to their in vivo counterparts.
Our approach will lead to more effective personalized-therapy for fertility preservation and contribute to the development of an in vitro mini-ovary organoid model to use in human reproductive toxicology and disease modelling.
Max ERC Funding
2 000 000 €
Duration
Start date: 2017-07-01, End date: 2022-06-30
Project acronym PERCENT
Project Percolating Entanglement and Quantum Information Resources through Quantum Networks
Researcher (PI) Antonio Acín
Host Institution (HI) FUNDACIO INSTITUT DE CIENCIES FOTONIQUES
Call Details Starting Grant (StG), PE2, ERC-2007-StG
Summary Quantum communication networks consist of several nodes that are connected by quantum channels. By exchanging quantum particles, the nodes share quantum correlations, also know as entanglement. Essential for the future development of quantum communication is to understand the design of efficient protocols for the distribution of entanglement between arbitrarily distant nodes. The main objective of the present proposal is to construct the theory of entanglement distribution through quantum networks. At present, very little is known about this fundamental problem, namely about which properties of a quantum network are required to be able to establish entanglement over large distances. Very recently, we have proved that the distribution of entanglement through quantum networks defines a new type of critical phenomenon, an entanglement phase transition called entanglement percolation. These surprising effects do not appear in the standard repeater configuration previously considered. Crucial for the construction of these examples is the use of concepts already known in statistical mechanics, such as percolation. Our scope is to go far beyond these proof-of principle examples and derive the general theoretical framework describing entanglement percolation, exploiting the connection between statistical concepts and entanglement theory. The obtained framework will also be applied to other information resources, such as secret bits. Then, the ultimate aim of the project is to provide a global picture of the distribution of quantum information resources over realistic quantum communication networks.
Summary
Quantum communication networks consist of several nodes that are connected by quantum channels. By exchanging quantum particles, the nodes share quantum correlations, also know as entanglement. Essential for the future development of quantum communication is to understand the design of efficient protocols for the distribution of entanglement between arbitrarily distant nodes. The main objective of the present proposal is to construct the theory of entanglement distribution through quantum networks. At present, very little is known about this fundamental problem, namely about which properties of a quantum network are required to be able to establish entanglement over large distances. Very recently, we have proved that the distribution of entanglement through quantum networks defines a new type of critical phenomenon, an entanglement phase transition called entanglement percolation. These surprising effects do not appear in the standard repeater configuration previously considered. Crucial for the construction of these examples is the use of concepts already known in statistical mechanics, such as percolation. Our scope is to go far beyond these proof-of principle examples and derive the general theoretical framework describing entanglement percolation, exploiting the connection between statistical concepts and entanglement theory. The obtained framework will also be applied to other information resources, such as secret bits. Then, the ultimate aim of the project is to provide a global picture of the distribution of quantum information resources over realistic quantum communication networks.
Max ERC Funding
699 600 €
Duration
Start date: 2008-11-01, End date: 2013-12-31
Project acronym PREDICT
Project PREcision medicine Drug combination testing In neuroblastoma organoids to guide Clinical Trials
Researcher (PI) Jan Jasper MOLENAAR
Host Institution (HI) PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV
Call Details Starting Grant (StG), LS7, ERC-2016-STG
Summary Neuroblastoma are pediatric tumors that respond poorly to chemotherapy and have a very poor prognosis. To improve treatment options, a global development towards precision medicine is ongoing. This strongly focusses on molecular genetic target identification in tumors and subsequent assigning patients to the best trials according to their molecular profile. Still it is difficult to predict which patients will benefit from these targeted compounds. In addition, if tumors do respond to single compound targeted therapy, they almost always relapse. These tumor evolution processes could be prevented by simultaneous intervention in different activated tumor pathways.
We now want to study how we can select patients that will most likely respond to a targeted compound and what combinations of targeted compounds are most effective? This can’t be tested in a clinical setting since the number of neuroblastoma patients that can be included in Phase1/2 trials is very small. Recent research shows that tumor organoids mimic human tumors and can effectively be used as xenograft in nude mice as well. These in vitro and in vivo models could be used as an alternative selection system for optimal combination treatment in a personalized approach.
The overall aim is now to test if combinations of targeted compounds can cause complete remission in neuroblastoma organoid model systems to select combination treatment options for personalized clinical trials
For this purpose we will generate neuroblastoma organoids that properly represents the complexity and heterogeneity of individual tumors and build a repository that represents the various subtypes of neuroblastoma tumors. We will identify synergistic compound combinations that are effective in neuroblastoma tumors that are characterized by specific molecular genetic aberrations. Thereby we will build an efficient pipeline to generate personalized models that can be used in precision medicine programs to perform compound validation.
Summary
Neuroblastoma are pediatric tumors that respond poorly to chemotherapy and have a very poor prognosis. To improve treatment options, a global development towards precision medicine is ongoing. This strongly focusses on molecular genetic target identification in tumors and subsequent assigning patients to the best trials according to their molecular profile. Still it is difficult to predict which patients will benefit from these targeted compounds. In addition, if tumors do respond to single compound targeted therapy, they almost always relapse. These tumor evolution processes could be prevented by simultaneous intervention in different activated tumor pathways.
We now want to study how we can select patients that will most likely respond to a targeted compound and what combinations of targeted compounds are most effective? This can’t be tested in a clinical setting since the number of neuroblastoma patients that can be included in Phase1/2 trials is very small. Recent research shows that tumor organoids mimic human tumors and can effectively be used as xenograft in nude mice as well. These in vitro and in vivo models could be used as an alternative selection system for optimal combination treatment in a personalized approach.
The overall aim is now to test if combinations of targeted compounds can cause complete remission in neuroblastoma organoid model systems to select combination treatment options for personalized clinical trials
For this purpose we will generate neuroblastoma organoids that properly represents the complexity and heterogeneity of individual tumors and build a repository that represents the various subtypes of neuroblastoma tumors. We will identify synergistic compound combinations that are effective in neuroblastoma tumors that are characterized by specific molecular genetic aberrations. Thereby we will build an efficient pipeline to generate personalized models that can be used in precision medicine programs to perform compound validation.
Max ERC Funding
1 406 250 €
Duration
Start date: 2017-03-01, End date: 2022-02-28
Project acronym QGP
Project Characterisation of a novel state of matter: The Quark-Gluon Plasma
Researcher (PI) Andre Mischke
Host Institution (HI) UNIVERSITEIT UTRECHT
Call Details Starting Grant (StG), PE2, ERC-2007-StG
Summary I propose to explore the properties of a novel state of matter, the Quark-Gluon Plasma (QGP), created by colliding atomic nuclei at the highest energy ever reached using triggered particle correlations. The QGP is predicted by the fundamental theory of strong interactions and is characterized by an equilibrated system of free quarks and gluons that are the constituents of atomic nuclei. My investigation of the QGP properties will give unique insights into the development of the early universe and the properties of matter under extreme conditions. Among other results, particle correlation measurements have revealed first compelling evidence for the existence of the QGP state. Due to the limited sensitivity of the used probes, the conclusions are to some extent qualitative rather than quantitative. To get a deeper understanding of the mechanisms at work I propose to study heavy-quark correlations and their in-medium modification in collisions of heavy nuclei by combining the information from different detection systems. I have verified the feasibility of this measurement at lower energies. I am currently one of the world’s experts in measuring heavy-quark correlations and I propose to perform such a measurement at the forefront particle accelerator, the Large Hadron Collider, located at the European Laboratory for Particle Physics CERN. My investigation will be done utilizing the dedicated ALICE (A Large Ion Collider Experiment) detector, which is most suited for measurements in heavy-ion collisions. I would like to do my project with one Postdoc and one Ph.D. student during a period of five years. My research team will be embedded in one of the leading institutes in the field of heavy-ion physics which provided a crucial hardware component to the ALICE experiment. My expertise and the outstanding working environment will guarantee high quality in performing my key measurement. The ALICE experiment will be the place of new discoveries.
Summary
I propose to explore the properties of a novel state of matter, the Quark-Gluon Plasma (QGP), created by colliding atomic nuclei at the highest energy ever reached using triggered particle correlations. The QGP is predicted by the fundamental theory of strong interactions and is characterized by an equilibrated system of free quarks and gluons that are the constituents of atomic nuclei. My investigation of the QGP properties will give unique insights into the development of the early universe and the properties of matter under extreme conditions. Among other results, particle correlation measurements have revealed first compelling evidence for the existence of the QGP state. Due to the limited sensitivity of the used probes, the conclusions are to some extent qualitative rather than quantitative. To get a deeper understanding of the mechanisms at work I propose to study heavy-quark correlations and their in-medium modification in collisions of heavy nuclei by combining the information from different detection systems. I have verified the feasibility of this measurement at lower energies. I am currently one of the world’s experts in measuring heavy-quark correlations and I propose to perform such a measurement at the forefront particle accelerator, the Large Hadron Collider, located at the European Laboratory for Particle Physics CERN. My investigation will be done utilizing the dedicated ALICE (A Large Ion Collider Experiment) detector, which is most suited for measurements in heavy-ion collisions. I would like to do my project with one Postdoc and one Ph.D. student during a period of five years. My research team will be embedded in one of the leading institutes in the field of heavy-ion physics which provided a crucial hardware component to the ALICE experiment. My expertise and the outstanding working environment will guarantee high quality in performing my key measurement. The ALICE experiment will be the place of new discoveries.
Max ERC Funding
850 000 €
Duration
Start date: 2008-09-01, End date: 2013-08-31
Project acronym QUANTIVIOL
Project Quantifying Quantum Gravity Violations of Causality and the Equivalence Principle
Researcher (PI) Benjamin Wolf FREIVOGEL
Host Institution (HI) UNIVERSITEIT VAN AMSTERDAM
Call Details Consolidator Grant (CoG), PE2, ERC-2016-COG
Summary Quantum gravity must violate at least one of three principles at the foundations of physics: unitarity, causality, or the equivalence principle. Recent theoretical work on black holes has shown that such violations are not limited to extremely short distances, where quantum gravity effects are expected, but also occur at distances much larger than the Planck scale. This work has revealed a huge gap in our understanding: we have no working criterion for when quantum gravity violations of the usual laws of physics are important.
This theoretical crisis is also an opportunity, since quantum gravity effects may be observable if they occur at longer distance scales. I propose a series of concrete calculations in two theoretical situations: ordinary black holes, which evaporate due to Hawking radiation, and black holes in spacetimes with negative cosmological constant, which do not evaporate. These calculations will quantify, for the first time, the size of these violations.The calculations make use of existing techniques and results derived by myself and others, but a focused effort is needed in order to put together all of the necessary ingredients into a coherent quantitative result.
We will then generalize our results beyond black holes to obtain a generally applicable formula. The final result will be an answer to one of the most important questions in quantum gravity: how large are quantum gravity violations of the usual laws of physics? The impact of successfully completing this project extends far beyond black hole physics. As one application, our results will either justify existing calculations of cosmological observables, or make a prediction that quantum gravity effects can be observed.
Summary
Quantum gravity must violate at least one of three principles at the foundations of physics: unitarity, causality, or the equivalence principle. Recent theoretical work on black holes has shown that such violations are not limited to extremely short distances, where quantum gravity effects are expected, but also occur at distances much larger than the Planck scale. This work has revealed a huge gap in our understanding: we have no working criterion for when quantum gravity violations of the usual laws of physics are important.
This theoretical crisis is also an opportunity, since quantum gravity effects may be observable if they occur at longer distance scales. I propose a series of concrete calculations in two theoretical situations: ordinary black holes, which evaporate due to Hawking radiation, and black holes in spacetimes with negative cosmological constant, which do not evaporate. These calculations will quantify, for the first time, the size of these violations.The calculations make use of existing techniques and results derived by myself and others, but a focused effort is needed in order to put together all of the necessary ingredients into a coherent quantitative result.
We will then generalize our results beyond black holes to obtain a generally applicable formula. The final result will be an answer to one of the most important questions in quantum gravity: how large are quantum gravity violations of the usual laws of physics? The impact of successfully completing this project extends far beyond black hole physics. As one application, our results will either justify existing calculations of cosmological observables, or make a prediction that quantum gravity effects can be observed.
Max ERC Funding
2 000 000 €
Duration
Start date: 2017-09-01, End date: 2022-08-31
Project acronym RACE
Project Rheumatoid Arthritis Caught Early: investigating biological mechanisms preceding chronification of joint inflammation to identify patients prior to presentation of classic chronic arthritis
Researcher (PI) Anna Helena Maria VAN DER HELM
Host Institution (HI) ACADEMISCH ZIEKENHUIS LEIDEN
Call Details Starting Grant (StG), LS7, ERC-2016-STG
Summary Rheumatoid Arthritis (RA) causes long lasting disability. At the time of clinically evident arthritis and diagnosis, the disease is already persisting, requiring long-term suppressive treatment. My overarching aim is to prevent chronic arthritis and RA by inhibiting the evolving auto-immune response in a pre-arthritis phase. Currently, identification of RA-patients before the classic presentation with clinically evident chronic arthritis is beyond the state of the art. I here aim to achieve this early recognition by increasing the mechanistic understanding of pre-arthritis phases.
I intend to study RA-specific auto-immune responses at the cellular and humoral level as well as markers reflecting local and systemic inflammation. These aspects are selected based on my world-wide validated rule to predict RA-development in early arthritis and on recent work on progression from Clinically Suspect Arthralgia (CSA) to clinical arthritis.
This project is now finally feasible, thanks to unique ‘pre-RA’ cohorts and cross-boundary preparatory work done with basic scientists, clinicians and engineers. My research concept is to integrate the products of separate trajectories in a longitudinal study and translate it to the clinic.
Patients with CSA will be studied serially in time. Using validated methods and novel techniques and insights we will: delineate molecular and predictive features of RA-specific auto-antibodies and auto-antibody secreting B-cells, identify improved markers of systemic inflammation and test and validate a computer-aided image analysis system to detect subclinical joint inflammation on MRI. Serial data will be combined to reveal interactions between markers and time relationships. Lastly a prediction model identifying imminent RA will be developed. The forefront position of my group allows national and international validation.
Together, this multidisciplinary and intersectorial project will open new horizons for preventive, targeted interventions.
Summary
Rheumatoid Arthritis (RA) causes long lasting disability. At the time of clinically evident arthritis and diagnosis, the disease is already persisting, requiring long-term suppressive treatment. My overarching aim is to prevent chronic arthritis and RA by inhibiting the evolving auto-immune response in a pre-arthritis phase. Currently, identification of RA-patients before the classic presentation with clinically evident chronic arthritis is beyond the state of the art. I here aim to achieve this early recognition by increasing the mechanistic understanding of pre-arthritis phases.
I intend to study RA-specific auto-immune responses at the cellular and humoral level as well as markers reflecting local and systemic inflammation. These aspects are selected based on my world-wide validated rule to predict RA-development in early arthritis and on recent work on progression from Clinically Suspect Arthralgia (CSA) to clinical arthritis.
This project is now finally feasible, thanks to unique ‘pre-RA’ cohorts and cross-boundary preparatory work done with basic scientists, clinicians and engineers. My research concept is to integrate the products of separate trajectories in a longitudinal study and translate it to the clinic.
Patients with CSA will be studied serially in time. Using validated methods and novel techniques and insights we will: delineate molecular and predictive features of RA-specific auto-antibodies and auto-antibody secreting B-cells, identify improved markers of systemic inflammation and test and validate a computer-aided image analysis system to detect subclinical joint inflammation on MRI. Serial data will be combined to reveal interactions between markers and time relationships. Lastly a prediction model identifying imminent RA will be developed. The forefront position of my group allows national and international validation.
Together, this multidisciplinary and intersectorial project will open new horizons for preventive, targeted interventions.
Max ERC Funding
1 500 000 €
Duration
Start date: 2017-10-01, End date: 2022-09-30
Project acronym REJUVENATION
Project Repair of Junctional Atrioventricular Conduction and Impulse Formation
Researcher (PI) Gerard BOINK
Host Institution (HI) ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM
Call Details Starting Grant (StG), LS7, ERC-2016-STG
Summary Background: To bypass hardware-related complication there have been substantial efforts to create biological pacemakers. Effective strategies have been identified and are now being refined for delivery of long-term function and clinical application. Yet, currently developed biological pacemakers only provide pacing to atrium or ventricle thereby aiming at ~20% of pacemaker patients. To unleash the full potential of biological pacing, targeting virtually every pacemaker patient, effective repair of atrio-ventricular (AV) conduction is crucial. With the arrival of advanced stem cell-based therapies, now is the time to meet this important challenge.
Objective: To develop a stem cell-based therapy that restores impulse formation and conduction at the interface between atrium and ventricle.
Approach: Human induced pluripotent stem cells (hiPSCs) will be used to produce cells with hallmark features of AV nodal cells. After in vitro testing, these cells will be implanted in vivo (together with biomaterials) to form AV bypass tracts in sheep that are in permanent AV block. In this setting, approaches will be tested for their ability to bridge electrical activity from the atrium to ventricle and protect the ventricle from atrial tachycardia. The final steps of this project focuses on the development of dedicated implantation catheters (in collaboration with Medtronic) and optimization of cellular constructs that are regulatory compliant and ready for clinical testing.
Impact: By developing novel therapies to re-establish AV impulse formation and conduction I will broaden the application area of biological pacing to nearly all patients. In Europe ~300.000 pacemakers are implanted annually representing cots of ~8 billion Euros. Five per cent of these implantations result in serious complications requiring re-implantation or other invasive treatments. Biological pacemakers are expected to reduce these complications, improve quality of life, and reduce healthcare costs.
Summary
Background: To bypass hardware-related complication there have been substantial efforts to create biological pacemakers. Effective strategies have been identified and are now being refined for delivery of long-term function and clinical application. Yet, currently developed biological pacemakers only provide pacing to atrium or ventricle thereby aiming at ~20% of pacemaker patients. To unleash the full potential of biological pacing, targeting virtually every pacemaker patient, effective repair of atrio-ventricular (AV) conduction is crucial. With the arrival of advanced stem cell-based therapies, now is the time to meet this important challenge.
Objective: To develop a stem cell-based therapy that restores impulse formation and conduction at the interface between atrium and ventricle.
Approach: Human induced pluripotent stem cells (hiPSCs) will be used to produce cells with hallmark features of AV nodal cells. After in vitro testing, these cells will be implanted in vivo (together with biomaterials) to form AV bypass tracts in sheep that are in permanent AV block. In this setting, approaches will be tested for their ability to bridge electrical activity from the atrium to ventricle and protect the ventricle from atrial tachycardia. The final steps of this project focuses on the development of dedicated implantation catheters (in collaboration with Medtronic) and optimization of cellular constructs that are regulatory compliant and ready for clinical testing.
Impact: By developing novel therapies to re-establish AV impulse formation and conduction I will broaden the application area of biological pacing to nearly all patients. In Europe ~300.000 pacemakers are implanted annually representing cots of ~8 billion Euros. Five per cent of these implantations result in serious complications requiring re-implantation or other invasive treatments. Biological pacemakers are expected to reduce these complications, improve quality of life, and reduce healthcare costs.
Max ERC Funding
1 499 995 €
Duration
Start date: 2017-04-01, End date: 2022-03-31
Project acronym STOP-HF
Project STEM CELL MODELS TO UNRAVEL THE SUSCEPTIBILITY AND RESILIENCE TO DEVELOP HEART FAILURE
Researcher (PI) Peter Van der Meer
Host Institution (HI) ACADEMISCH ZIEKENHUIS GRONINGEN
Call Details Starting Grant (StG), LS7, ERC-2016-STG
Summary The overarching objective of STOP-HF is to generate human induced pluripotent stem cells (hiPSC) derived cardiomyocytes from two specific forms of heart failure (HF) with a clear trigger to unravel common pathophysiological mechanisms involved in the early development of HF. The project is focused on two specific forms of HF, both with a clear trigger: pregnancy and anthracyclines.
Better understanding of early molecular pathways leading to HF and knowledge about inter-individual susceptibility is needed.
For detection of early changes on a molecular level cardiac tissue is needed.
Generation of patient specific cardiac cells from skin fibroblasts (hiPSC technology) is a novel and innovative approach.
SPECIFIC OBJECTIVES
1. Fabrication and maturation of 3D cardiac tissue from hiPS derived cardiomyocytes.
2. Generate and characterize hiPS derived cardiomyocytes and endothelial cells from females with pregnancy induced HF and unravel differences on transcriptome level.
3. Generate and characterize hiPSC derived cardiomyocytes from patients with high susceptibility and resilience to develop anthracycline-induced HF and compare them on transcriptome level.
4. Integrate the results for coding and non-coding RNAs from objective 1+2 and identify overlapping pathways.
5. Validate discoveries on transcriptome level in vitro, in vivo and apply for the development of HF in the general population.
WORKPACKAGES
WP1: Optimize fabrication and maturation of 3D cardiac tissue from hiPS derived cardiomyocytes
WP 2A:Validate the model and compare hiPS derived cardiomyocytes and endothelial cells from PPCM and healthy sisters on transcriptome level;
WP 2B:Validate the model and compare hiPS derived cardiomyocytes from both patients with high susceptibility and resilience to develop HF after anthracyclins on transcriptome level;
WP 3:Integration of transcriptome data from WP 2A+2B;
WP 4:Validation of novel pathways in vitro, in vivo and new onset HF in the general population.
Summary
The overarching objective of STOP-HF is to generate human induced pluripotent stem cells (hiPSC) derived cardiomyocytes from two specific forms of heart failure (HF) with a clear trigger to unravel common pathophysiological mechanisms involved in the early development of HF. The project is focused on two specific forms of HF, both with a clear trigger: pregnancy and anthracyclines.
Better understanding of early molecular pathways leading to HF and knowledge about inter-individual susceptibility is needed.
For detection of early changes on a molecular level cardiac tissue is needed.
Generation of patient specific cardiac cells from skin fibroblasts (hiPSC technology) is a novel and innovative approach.
SPECIFIC OBJECTIVES
1. Fabrication and maturation of 3D cardiac tissue from hiPS derived cardiomyocytes.
2. Generate and characterize hiPS derived cardiomyocytes and endothelial cells from females with pregnancy induced HF and unravel differences on transcriptome level.
3. Generate and characterize hiPSC derived cardiomyocytes from patients with high susceptibility and resilience to develop anthracycline-induced HF and compare them on transcriptome level.
4. Integrate the results for coding and non-coding RNAs from objective 1+2 and identify overlapping pathways.
5. Validate discoveries on transcriptome level in vitro, in vivo and apply for the development of HF in the general population.
WORKPACKAGES
WP1: Optimize fabrication and maturation of 3D cardiac tissue from hiPS derived cardiomyocytes
WP 2A:Validate the model and compare hiPS derived cardiomyocytes and endothelial cells from PPCM and healthy sisters on transcriptome level;
WP 2B:Validate the model and compare hiPS derived cardiomyocytes from both patients with high susceptibility and resilience to develop HF after anthracyclins on transcriptome level;
WP 3:Integration of transcriptome data from WP 2A+2B;
WP 4:Validation of novel pathways in vitro, in vivo and new onset HF in the general population.
Max ERC Funding
1 496 875 €
Duration
Start date: 2017-03-01, End date: 2022-02-28
Project acronym SUMO
Project Study of the role of protein posttranslational modification by SUMO (Small Ubiquitin-like MOdifier) in abscisic acid signaling and stress responses in plants
Researcher (PI) Luisa Maria Lois
Host Institution (HI) CENTRE DE RECERCA EN AGRIGENOMICA CSIC-IRTA-UAB-UB
Call Details Starting Grant (StG), LS7, ERC-2007-StG
Summary Eukaryotic protein function is regulated in vivo by diverse mechanisms such as protein turnover, regulation of protein activity, localization and protein-protein interactions. These mechanisms involve constitutive or reversible post-translational modifications of specific amino-acid residues in the target protein by molecules of different nature. Ubiquitin and ubiquitin-like modifiers are polypeptides that are covalently attached to a lysine residue in the target protein. SUMO is a member of the ubiquitin family, but it differs from ubiquitin in its cellular function. Whereas protein ubiquitination results in degradation by the 26S proteasome, sumoylation is involved in regulation of protein activity, cellular localization, or protection from ubiquitination. In plants, SUMO plays an important role in biotic and abiotic stress responses, and regulates abscisic acid (ABA) signaling, plant hormone that mediates environmental stress responses, and flowering. In addition, we have found that a functional sumoylation system is essential during seed development, process that is also regulated by ABA at different stages. Our general goal is to investigate the biological role of SUMO in the context of ABA signaling and stress responses in Arabidopsis. For this purpose we will study different aspects of this novel posttranslational regulatory system involving the analysis of the SUMO biological role during seed development and germination, identification of new SUMO targets and dissection of the biological role of the catalase AtCAT3 sumoylation, and the study of molecular factors that could be responsible for recognition of SUMO conjugates. The data generated will contribute to better understanding of this biological process and, eventually, to a thoughtful design of plants with improved agronomical traits. Also, as sumoylation is an evolutionary conserved regulatory system, our work will greatly contribute to understand its mechanism of action in mammals.
Summary
Eukaryotic protein function is regulated in vivo by diverse mechanisms such as protein turnover, regulation of protein activity, localization and protein-protein interactions. These mechanisms involve constitutive or reversible post-translational modifications of specific amino-acid residues in the target protein by molecules of different nature. Ubiquitin and ubiquitin-like modifiers are polypeptides that are covalently attached to a lysine residue in the target protein. SUMO is a member of the ubiquitin family, but it differs from ubiquitin in its cellular function. Whereas protein ubiquitination results in degradation by the 26S proteasome, sumoylation is involved in regulation of protein activity, cellular localization, or protection from ubiquitination. In plants, SUMO plays an important role in biotic and abiotic stress responses, and regulates abscisic acid (ABA) signaling, plant hormone that mediates environmental stress responses, and flowering. In addition, we have found that a functional sumoylation system is essential during seed development, process that is also regulated by ABA at different stages. Our general goal is to investigate the biological role of SUMO in the context of ABA signaling and stress responses in Arabidopsis. For this purpose we will study different aspects of this novel posttranslational regulatory system involving the analysis of the SUMO biological role during seed development and germination, identification of new SUMO targets and dissection of the biological role of the catalase AtCAT3 sumoylation, and the study of molecular factors that could be responsible for recognition of SUMO conjugates. The data generated will contribute to better understanding of this biological process and, eventually, to a thoughtful design of plants with improved agronomical traits. Also, as sumoylation is an evolutionary conserved regulatory system, our work will greatly contribute to understand its mechanism of action in mammals.
Max ERC Funding
1 104 000 €
Duration
Start date: 2008-07-01, End date: 2014-06-30
Project acronym TOHPN
Project Towards the optimization of hydrogen production by nitrogenase
Researcher (PI) Luis Manuel Rubio Herrero
Host Institution (HI) UNIVERSIDAD POLITECNICA DE MADRID
Call Details Starting Grant (StG), LS7, ERC-2007-StG
Summary In nature, molecular hydrogen is produced by the hydrogenase and the nitrogenase enzymes. Nitrogenase reduces dinitrogen to ammonia and, in this process, it evolves hydrogen. Nitrogenase and hydrogenase are oxygen-sensitive enzymes. We chose to optimize a hydrogen production system based on nitrogenase for four reasons: some organisms carrying nitrogenase simultaneously perform photosynthesis and hydrogen evolution by nitrogenase (direct biophotolysis), thus harvesting solar energy and autonomously converting it into chemical energy in a continuous process; cellular mechanisms exist to protect nitrogenase from oxygen but do not appear to exist for hydrogenase; because nitrogenase couples ATP hydrolysis to hydrogen evolution, this enzyme is able to generate hydrogen against a substantial gas pressure; finally, the biochemistry of the nitrogenase system is well known. The objective of our proposal is to provide new eco-efficient strategies for the biological production of hydrogen. Energy research is a priority theme under the Seventh Research Framework (FP7) cooperation program. The objective of energy research under FP7 is to adapt the current energy system into a more sustainable, competitive and secure one, with emphasis and support given to hydrogen research and renewable fuel production. Our proposal has three major components: (i) in vitro evolution of nitrogenase, in which we generate new nitrogenase variants by metagenomic gene shuffling and random mutagenesis, and select those with increased hydrogen production activity; (ii) the development of a genetic system to select for hydrogen overproducers; and (iii) a biochemical element designed to understand the biochemical requisites for efficient hydrogen production by the molybdenum nitrogenase as a basis for its re-engineering.
Summary
In nature, molecular hydrogen is produced by the hydrogenase and the nitrogenase enzymes. Nitrogenase reduces dinitrogen to ammonia and, in this process, it evolves hydrogen. Nitrogenase and hydrogenase are oxygen-sensitive enzymes. We chose to optimize a hydrogen production system based on nitrogenase for four reasons: some organisms carrying nitrogenase simultaneously perform photosynthesis and hydrogen evolution by nitrogenase (direct biophotolysis), thus harvesting solar energy and autonomously converting it into chemical energy in a continuous process; cellular mechanisms exist to protect nitrogenase from oxygen but do not appear to exist for hydrogenase; because nitrogenase couples ATP hydrolysis to hydrogen evolution, this enzyme is able to generate hydrogen against a substantial gas pressure; finally, the biochemistry of the nitrogenase system is well known. The objective of our proposal is to provide new eco-efficient strategies for the biological production of hydrogen. Energy research is a priority theme under the Seventh Research Framework (FP7) cooperation program. The objective of energy research under FP7 is to adapt the current energy system into a more sustainable, competitive and secure one, with emphasis and support given to hydrogen research and renewable fuel production. Our proposal has three major components: (i) in vitro evolution of nitrogenase, in which we generate new nitrogenase variants by metagenomic gene shuffling and random mutagenesis, and select those with increased hydrogen production activity; (ii) the development of a genetic system to select for hydrogen overproducers; and (iii) a biochemical element designed to understand the biochemical requisites for efficient hydrogen production by the molybdenum nitrogenase as a basis for its re-engineering.
Max ERC Funding
1 968 000 €
Duration
Start date: 2008-10-01, End date: 2014-09-30
Project acronym TRICEPS
Project Time-resolved Ring-Cavity-Enhanced Polarization Spectroscopy: Breakthroughs in measurements of a) Atomic Parity Violation, b) Protein conformation and biosensing and c) surface and thin film dynamics
Researcher (PI) Theodore Peter Rakitzis
Host Institution (HI) FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS
Call Details Starting Grant (StG), PE2, ERC-2007-StG
Summary Polarimetry is a crucial tool in both fundamental and applied physics, ranging from the measurement of parity nonconservation (PNC) in atoms, to the determination of biomolecule structure, and the probing of interfaces. These measurements tend to be extremely challenging as the change of the polarization of light is usually extremely small; typical differences in polarization states are of the order of 10^-5 to 10^-8. Current experimental techniques often require acquisition times of the order of seconds or, in the case of PNC, even many days, limiting the possibilities of time-resolved measurements. Here, I propose to develop optical-cavity-based techniques which will enhance measurements of the polarization sensitivity and/or the time-resolution by 3-6 orders of magnitude. Preliminary data from prototypes and feasibility studies are presented. I propose to demonstrate how these breakthroughs will revolutionize polarimetry, by addressing some of the most important multidisciplinary problems in fundamental physics, biophysics, and material science: a) Testing the limits of the Standard Model with atomic PNC measurements. Current PNC experiments, and more importantly theory, for cesium atoms are limited to precision of about 0.5%. The novel and robust experimental technique I am proposing here affords 4 orders-of-magnitude higher sensitivity, thus giving access to lighter atoms, where the theory can be better than 0.1%, for the most stringent test of the Standard Model, while seeking new physics. b) The measurement of protein folding dynamics. Highly sensitive time-resolved spectroscopic ellipsometry, providing novel dynamical information on protein folding: nanosecond resolved, position measurements of functional groups of surface proteins, which map out the time-dependent protein structure. c) Determination of thin film thickness and surface density with nanosecond resolution, for the study of processes such as laser ablation and polymer growth.
Summary
Polarimetry is a crucial tool in both fundamental and applied physics, ranging from the measurement of parity nonconservation (PNC) in atoms, to the determination of biomolecule structure, and the probing of interfaces. These measurements tend to be extremely challenging as the change of the polarization of light is usually extremely small; typical differences in polarization states are of the order of 10^-5 to 10^-8. Current experimental techniques often require acquisition times of the order of seconds or, in the case of PNC, even many days, limiting the possibilities of time-resolved measurements. Here, I propose to develop optical-cavity-based techniques which will enhance measurements of the polarization sensitivity and/or the time-resolution by 3-6 orders of magnitude. Preliminary data from prototypes and feasibility studies are presented. I propose to demonstrate how these breakthroughs will revolutionize polarimetry, by addressing some of the most important multidisciplinary problems in fundamental physics, biophysics, and material science: a) Testing the limits of the Standard Model with atomic PNC measurements. Current PNC experiments, and more importantly theory, for cesium atoms are limited to precision of about 0.5%. The novel and robust experimental technique I am proposing here affords 4 orders-of-magnitude higher sensitivity, thus giving access to lighter atoms, where the theory can be better than 0.1%, for the most stringent test of the Standard Model, while seeking new physics. b) The measurement of protein folding dynamics. Highly sensitive time-resolved spectroscopic ellipsometry, providing novel dynamical information on protein folding: nanosecond resolved, position measurements of functional groups of surface proteins, which map out the time-dependent protein structure. c) Determination of thin film thickness and surface density with nanosecond resolution, for the study of processes such as laser ablation and polymer growth.
Max ERC Funding
909 999 €
Duration
Start date: 2009-01-01, End date: 2014-12-31